Cancer - Leukemia

Get Adobe Flash Player to see this content.

Obese Children With Leukemia Are Less Responsive to Chemo

A new study finds obese children suffering from leukemia are less responsive to chemotherapy-- and more likely to relapse.

All Media | Only Audio | Only Video
Sort By: Date | Relevance
Obese Children With

Obese Children With Leukemia Are Less Responsive to Chemo

A new study finds obese children suffering from leukemia are less responsive to chemotherapy-- and more likely to relapse.

Study Reveals Safter Treatments for

Study Reveals Safter Treatments for Leukemia

A study suggests there's a way to fight leukemia without exposing patients to treatments that could cause brain damage.


Green Tea May Help Fight

Green Tea May Help Fight Leukemia

A compound found in green tea may help patients with leukemia battle their disease.

A Young Boy Battles

A Young Boy Battles Leukemia , Awaits Bone Marrow Match

A young boy battles leukemia while waiting for a bone marrow transplant. Seven out of 10 patients never get one.


 Explained

Leukemia Explained

The most common type of leukemia is chronic lymphocytic leukemia .

The Faulty Gene Behind Chronic Myeloid

The Faulty Gene Behind Chronic Myeloid Leukemia

The genetics of chronic myeloid leukemia are now well understood. But it took over 40 years to figure it out. Listen to pioneering scientists as they explain their discoveries, including one made on a dining room table.


Monitoring Therapy in Chronic Myeloid

Monitoring Therapy in Chronic Myeloid Leukemia

Chronic myeloid leukemia , or CML (sometimes called chronic myelogenous leukemia ) is a cancer of white blood cells.

A Boy Receives Bone Marrow From His Brother

A Boy Receives Bone Marrow From His Brother

A boy's life is saved from leukemia when his brother donates bone marrow.


Facts to Know While Undergoing Therapy for CML

Facts to Know While Undergoing Therapy for CML

Learn about the decision-making process when choosing a therapy for Chronic Myeloid Leukemia

Monitoring and Adherence in CML

Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years.